GERD Perspective

 
 
  • 9 Things to Know About ARFID Identifying and treating the newly minted condition of avoidant restrictive food intake disorder requires asking the right questions, according to Dr William Balistreri.
  • What's It Like to Take Ozempic? A Doctor's Own Story With the rising popularity of weight loss drug injections, you may be getting many more questions from patients. Here, a doctor shares her own experience of taking these medications.
  • Can Artificial Intelligence Chat Bots Help Prevent Suicide?   Arthur L. Caplan, PhD, discusses the future of artificial intelligence in mental health.
  • GI Presentations of Allergic and Immunologic Diseases Allergic conditions often present with GI symptoms. It's important to recognize the signs and know how to proceed.
  • ACG 2022 ACG 2022: Colorectal Cancer Screening, and GI and Liver Disease   Vivek Kaul, MD, discusses new data in primary care from the American College of Gastroenterology 2022 annual meeting.
  • Immune Thrombocytopenia: Protecting Endangered Platelets: New Directions   USC clinicians explore new directions in ITP research, including genetics and promising therapies such as Bruton tyrosine kinase inhibitors.
  • Highlights in Esophageal Research From ACG 2022   Highlights in esophageal diseases from ACG 2022 include data on use of dupilumab in eosinophilic esophagitis, achalasia as risk for esophageal cancer, and vonoprazan in nonerosive reflux disease.
  • 13 Highlights From ACG 2022   Dr David Johnson shares the latest data from this year's meeting, which range from novel treatments for C difficile to the use of virtual reality in treating dyspepsia.
  • Comorbidities in IPF: Compounding a Heavy Burden: Promising Leads   Yale physicians and researchers report promising new directions in IPF drug research in the face of setbacks to clinical trials during the COVID pandemic.
  • How Anthem Gets Away With Nonpayment and Denials   Dr Robert Glatter and Dr Andrew Fenton join Andrew Selesnick and James Blakeman to discuss a disturbing pattern of nonpayment and denials by the insurer Anthem.
  • Episode 4: Team Effort: Multidisciplinary Approach to Severe Asthma   Drs Wechsler and Jackson discuss their partnerships with nurses, asthma educators, psychologists, speech therapists, and other specialists when diagnosing and treating patients with severe asthma.
  • Comorbidities in IPF: Addressing Symptoms   Yale doctors explain their approach to treating patients with both idiopathic pulmonary fibrosis and pulmonary hypertension and describe promising therapies.
  • How Much Weight Does My Patient Need to Lose? Dr Donna Ryan discusses why we need to think of weight loss in terms of percentages, not pounds shed, and provides insight into how as little as a 5% loss can improve individual health.
  • When Not to Skip H pylori Testing   A quick review of when, how, and why to test for Helicobacter pylori.
  • Diffuse Urticarial Eruptions After COVID-19 Vaccination Many common side effects of the COVID-19 vaccine are dermatologic. Dr Stadtmauer discusses seven patients he has treated personally.
  • 8 Must-Read GI Studies for the Primary Care Physician   Gastroenterologist Vivek Kaul, MD, reviews his top picks for primary care clinicians from the 2022 Digestive Disease Week, the premier meeting for the GI specialty.
  • Esophageal Diseases Highlights From DDW 2022   From DDW 2022, Dr Sachin Wani reports on key studies in esophageal disease, including results comparing vonoprazan and lansoprazole, and data from the 96-week extension study of the EOS-2 trial.
  • DDW 2022 10 Highlights From Digestive Disease Week 2022   With a focus on newly approved treatments and those seemingly on the verge, this year's meeting had clear practice-changing implications, says Dr David Johnson.
  • DDW 2022 Read clinically focused news coverage of key developments from DDW 2022
  • Comorbidities in IPF: Compounding a Heavy Burden   Pulmonologists at Yale School of Medicine explain idiopathic pulmonary fibrosis (IPF); the impact of comorbidities on this incurable, progressive disease; and new directions in drug research.